Primary Category:
Treatment Protocols
Disease Category:
Bladder, Genitourinary
Status:
Open, Temporarily Closed
Phase III Randomized Adjuvant study of MK-3475 (Pembrolizumab) in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
NCT#03244384
Eligible for screening study DCP 001
A031501 is temporarily closed to new patient accrual pending implementation of Update 8 revised documents, effective July 6, 2021.
